ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.135
      -0.43%
      Bitcoin
      55,245.68
      -1.08%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celgene Corporation (CELG)

      7. Celgene Corporation (CELG) News

      CELG

      Celgene (CELG)

      Celgene Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CELG
      DateTimeSourceHeadlineSymbolCompany
      06/24/20196:59AMBusiness WireBristol-Myers Squibb Provides Update on Pending Merger with CelgeneNASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20194:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/17/20198:13AMDow Jones NewsBeiGene Says Agrees to End Collaboration With CelgeneNASDAQ:CELGCelgene Corporation
      06/14/20199:00AMPR Newswire (US)Leoplus USA Wins Lyfebulb-Celgene 2019 "Addressing Unmet Needs in MS: An Innovation Challenge"NASDAQ:CELGCelgene Corporation
      06/13/20198:56AMDow Jones NewsMereo BioPharma Says Celgene Won't License EtigilimabNASDAQ:CELGCelgene Corporation
      06/06/20197:30AMBusiness WireUS FDA and EMA Accept Applications for Ozanimod for the Treatment of Relapsing Forms of Multiple SclerosisNASDAQ:CELGCelgene Corporation
      06/06/20193:02AMDow Jones NewsBristol to Shuffle R&D Executives -- WSJNASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20194:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      06/05/20197:28AMDow Jones NewsBristol R&D Chief to Leave After Celgene AcquisitionNASDAQ:CELGCelgene Corporation
      06/05/20196:59AMBusiness WireBristol-Myers Squibb Announces Post-Closing Leadership TeamNASDAQ:CELGCelgene Corporation
      06/04/201911:00AMBusiness WireCelgene Announces Data from Ongoing Studies of Liso-Cel in Patients with Difficult-to-Treat Blood Cancers at ASCO 2019NASDAQ:CELGCelgene Corporation
      06/04/20198:24AMDow Jones NewsFDA Accepts Celgene, Acceleron BLA for Anemia Drug LuspaterceptNASDAQ:CELGCelgene Corporation
      06/04/20197:30AMBusiness WireCelgene Corp. & Acceleron Pharma Announce U.S. FDA Accepts Luspatercept Biologics License Application in Myelodysplastic Synd...NASDAQ:CELGCelgene Corporation
      06/03/20199:00AMBusiness WireCelgene Updated Analysis of JAKARTA2 Fedratinib Study Shows Clinically Meaningful Responses in Patients Previously Treated fo...NASDAQ:CELGCelgene Corporation
       Showing the most relevant articles for your search:NASDAQ:CELG